Abstracts tagged "CMS"

Abstract Number: 1313 • 2019 ACR/ARP Annual Meeting
Readmissions After Staged vs Simultaneous Bilateral Total Knee Replacements (TKR)
Linda Russell¹, Bella Mehta ², Emily Lai ³, Jackie Finik ⁴, Haley Tornberg ⁵, Huong Do ¹, Anne Bass ⁶, Peter Sculco ¹, Thomas Sculco ⁵, Lazaros Poultsides ⁷, Stavros Memtsoudis ⁵ and Susan Goodman ⁶, ¹Hospital for Special Surgery, New York, ²Hospital for Special Surgery/Weill Cornell Medicine, New York, ³Hospital for Special Surgery Healthcare Research Institute, New York, NY, ⁴Hospital for Special Surgery, New York, NY, New York, NY, ⁵Hospital for Special Surgery, New York, NY, ⁶Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ⁷NYU Langone Health, New York, NY
Background/Purpose: The safety of bilateral total knee replacements (BTKR) under the same anesthesia as compared to staging within 12 months is debated. The advantage is…
Abstract Number: 1242 • 2018 ACR/ARHP Annual Meeting
Rheumatologists Participating in the RISE Registry Succeeded in the First Year of the Merit-Based Incentive Payment System (MIPS)
Tracy Johansson¹, Ryan Larosa², Rachel Myslinski³, Norlita Brown¹, Lindsay Lewis¹ and Jinoos Yazdany⁴, ¹Practice, Advocacy & Quality, American College of Rheumatology, Atlanta, GA, ²American College of Rheumatology, Atlanta, GA, ³Practice, Advocacy, & Quality, American College of Rheumatology, Atlanta, GA, ⁴University of California, San Francisco, San Francisco, CA
Background/Purpose: Under the Medicare Access and CHIP Reauthorization Act (MACRA), rheumatologists face financial repercussions through the Merit-Based Incentive Payment System (MIPS) based on performance on…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].